Pharma news
Americas
The US Court of Appeals for the Federal Circuit has ruled that biosimilar applicants can opt out of the so-called patent dance, paving the way for Sandoz to sell a biosimilar version of an Amgen drug. 22 July 2015
Pharma
A new parliamentary group has been created to raise awareness of and help to develop the life sciences industry in the UK. 21 July 2015
Americas
The Patent Trial and Appeal Board has partly accepted pharmaceutical company Lupin Limited’s petition for an inter partes review of claims in a patent covering a compound that helps to treat HIV. 16 July 2015
Pharma
Despite its troubled start, Brazil’s Product Development Partnerships programme is now entering a new stage of its development with the introduction of a more complete system for regulation, but there’s also more scope for patent infringement, say Otto Licks and Ricardo Campello of Licks Attorneys. 16 July 2015
Asia
AstraZeneca has agreed a deal with drug maker Kyowa Hakko Kirin giving the UK pharmaceutical company the option to commercialise an asthma treatment in Japan. 16 July 2015
Americas
US law firm Haynes and Boone has expanded its intellectual property practice by hiring two partners. 13 July 2015
Americas
Pharmaceutical company Teva has become the first business to launch a generic version of Janssen Pharmaceuticals’s migraine treatment drug Axert (almotriptan malate). 13 July 2015
Americas
Law firm Fenwick & West has expanded its life sciences practice by hiring Daniel Becker as partner. 10 July 2015
Asia
India’s progressive IP policies—and its status as ‘pharmacy of the developing world’ and lifeline for millions of people—are now under threat from many fronts. Yuanqiong Hu, IP advisor for Médecins Sans Frontières’s Access Campaign, explains more. 9 July 2015
Americas
UK-based life sciences research charity MRC Technology has hired Andrew Farquharson as its director of technology transfer. 8 July 2015